Cybermedlife - Therapeutic Actions Art Therapy

A randomized trial to test the effectiveness of art therapy for children with asthma.

Abstract Title: A randomized trial to test the effectiveness of art therapy for children with asthma. Abstract Source: J Allergy Clin Immunol. 2010 Aug;126(2):263-6, 266.e1. Epub 2010 May 11. PMID: 20462632 Abstract Author(s): Anya Beebe, Erwin W Gelfand, Bruce Bender Article Affiliation: Pediatric Behavioral Health, National Jewish Health, Denver, Colo, USA. Abstract: BACKGROUND: Art therapy has been used to help children cope with chronic illness but has not been specifically tested with children who have asthma. OBJECTIVE: To test an art therapy intervention in a randomized controlled trial in children with asthma. METHODS: Twenty-two children with asthma were randomized to an active art therapy or wait-list control group. Those in the active art therapy group participated in 60-minute art therapy sessions once a week for 7 weeks. Sessions included specific art therapy tasks designed to encourage expression, discussion, and problem-solving in response to the emotional burden of chronic illness. Measures taken at baseline, immediately after, and 6 months after the final art therapy session included the Formal Elements Art Therapy Scale applied to the Person Picking an Apple from a Tree assessment, the parent and child versions of the Pediatric Quality of Life Asthma Module, and the Beck Youth Inventories. Those children assigned to the wait-list control group completed all evaluations at the same intervals as the children receiving art therapy but did not receive the art therapy interventions. RESULTS: Score changes from baseline to completion of art therapy indicated (1) improved problem-solving and affect drawing scores; (2) improved worry, communication, and total quality of life scores; and (3) improved Beck anxiety and self concept scores in the active group relative to the control group. At 6 months, the active group maintained some positive changes relative to the control group including (1) drawing affect scores, (2) the worry and quality of life scores, and (3) the Beck anxiety score. Frequency of asthma exacerbations before and after the 6-month study interval did not differ between the 2 groups. CONCLUSION: This was the first randomized trial demonstrating that children with asthma receive benefit from art therapy that includes decreased anxiety and increased quality of life. Article Published Date : Aug 01, 2010
Therapeutic Actions Art Therapy

NCBI pubmed

Adipose-derived stem cell therapies for bone regeneration.

Related Articles Adipose-derived stem cell therapies for bone regeneration. Expert Opin Biol Ther. 2017 Jun;17(6):677-689 Authors: Barba M, Di Taranto G, Lattanzi W Abstract INTRODUCTION: Cell-based therapies exploit the heterogeneous and self-sufficient biological environment of stem cells to restore, maintain and improve tissue functions. Adipose-derived stem cells (ASCs) are, to this aim, promising cell types thanks to advantageous isolation procedures, growth kinetics, plasticity and trophic properties. Specifically, bone regeneration represents a suitable, though often challenging, target setting to test and apply ASC-based therapeutic strategies. Areas covered: ASCs are extremely plastic and secrete bioactive peptides that mediate paracrine functions, mediating their trophic actions in vivo. Numerous preclinical studies demonstrated that ASCs improve bone healing. Clinical trials are ongoing to validate the clinical feasibility of these approaches. This review is intended to define the state-of-the-art on ASCs, encompassing the biological features that make them suitable for bone regenerative strategies, and to provide an update on existing preclinical and clinical applications. Expert opinion: ASCs offer numerous advantages over other stem cells in terms of feasibility of clinical translation. Data obtained from in vivo experimentation are encouraging, and clinical trials are ongoing. More robust validations are thus expected to be achieved during the next few years, and will likely pave the way to optimized patient-tailored treatments for bone regeneration. PMID: 28374644 [PubMed - indexed for MEDLINE]